Physician

David Chaar, MD

According to 2025 Medicare claims, David Chaar, MD (NPI: 1417454356) practices neurology in the Sherman-Denison, TX market, with the plurality of this provider's patient population coming from Grayson, TX. This provider's primary affiliated billing organization is TEXOMA NEUROLOGY ASSOCIATES, PA (NPI: 1669470092; TIN: 751739707) and primary practice location at 75092-7371. Chaar is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Chaar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 429 traditional Medicare patients, billed 7,179 HCPCS/CPT codes, and received $263,506 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,291 prescription claims across 296 beneficiaries totaling $704,809 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). Open Payments data shows 40 records totaling $787. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,000 to $704,809. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$132K$264K2023 Medicare payment: $18,637 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $263,506 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202365304$18,637
20244297,179$263,506

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$352K$705K2018 Drug cost: $1,000 (USD; Tot_Drug_Cst)2019 Drug cost: $13,846 (USD; Tot_Drug_Cst)2020 Drug cost: $14,316 (USD; Tot_Drug_Cst)2021 Drug cost: $5,039 (USD; Tot_Drug_Cst)2022 Drug cost: $19,158 (USD; Tot_Drug_Cst)2023 Drug cost: $21,950 (USD; Tot_Drug_Cst)2024 Drug cost: $704,809 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181231$1,000
201956208$13,846
202053155$14,316
20212796$5,039
202230127$19,158
202365133$21,950
20242962,291$704,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more7171$142
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more120165$114
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more193284$94
95886Needle measurement of electrical activity in arm or leg muscles, complete study81209$69
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's205353$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5012336$61,341
UbrelvyUbrogepant25750$37,878
QuliptaAtogepant27810$29,200
Emgality SyringeGalcanezumab-Gnlm16480$11,564
LacosamideLacosamide301,188$10,044

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$787PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Chaar, MD?

Tedicare shows public-source Medicare data for David Chaar, MD (NPI 1417454356), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Chaar, MD have ACO affiliation data?

David Chaar, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David Chaar, MD?

David Chaar, MD is linked to TEXOMA NEUROLOGY ASSOCIATES, PA (billing NPI 1669470092) in the available physician profile data.

Does David Chaar, MD have Open Payments data?

David Chaar, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.